Skip to main content
Erschienen in: World Journal of Urology 6/2015

01.06.2015 | Original Article

The blind spots in follow-up after nephrectomy or nephron-sparing surgery for localized renal cell carcinoma

verfasst von: Tim J. van Oostenbrugge, Stephanie G. C. Kroeze, J. L. H. Ruud Bosch, Harm H. E. van Melick

Erschienen in: World Journal of Urology | Ausgabe 6/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This study was conducted to identify time to and type of recurrence in relation to scheduled follow-up (FU) imaging after nephrectomy or nephron-sparing surgery for localized renal cell carcinoma (RCC). Using this information, future guidelines could improve the early detection of metastases.

Methods

Measured from moment of treatment, all recurrences after (partial) nephrectomy performed between 2000 and 2010 were categorized as being detected early (<6 months), late (>5 year for T1/T2 and >10 year for T3/T4), or intermediate (time within those two) based on European Association of Urology (EAU) guidelines. Also symptomatic presentation was screened.

Results

Recurrent disease developed in 80 of 396 patients after (partial) tumor nephrectomy. Mean time to recurrence in months was 56 (n = 21) for T1, 24 (n = 18) for T2, 21 (n = 38) for T3, and 11 (n = 2) for T4 tumors. Detection of early recurrence occurred in 22 patients (28 %), of which 20 (91 %) were T2–T4 tumors. In 10 (48 %) of T1 tumors, late recurrence was found. Of the patients with symptoms due to recurrence, 65 % (17/26) were detected outside the FU surveillance protocol (P = 0.01).

Conclusion

A more intensive FU the first 6 months after nephrectomy for T2–T4 and FU imaging ≥5 years after surgery for T1 tumors might improve early and asymptomatic detection of recurrent disease after nephrectomy for RCC.
Literatur
1.
2.
Zurück zum Zitat Levi F et al (2008) The changing pattern of kidney cancer incidence and mortality in Europe. BJU Int 101(8):949–958CrossRefPubMed Levi F et al (2008) The changing pattern of kidney cancer incidence and mortality in Europe. BJU Int 101(8):949–958CrossRefPubMed
4.
Zurück zum Zitat Lightfoot N et al (2000) Impact of noninvasive imaging on increased incidental detection of renal cell carcinoma. Eur Urol 37(5):521–527CrossRefPubMed Lightfoot N et al (2000) Impact of noninvasive imaging on increased incidental detection of renal cell carcinoma. Eur Urol 37(5):521–527CrossRefPubMed
5.
Zurück zum Zitat Chow WH et al (1999) Rising incidence of renal cell cancer in the United States. JAMA 281(17):1628–1631CrossRefPubMed Chow WH et al (1999) Rising incidence of renal cell cancer in the United States. JAMA 281(17):1628–1631CrossRefPubMed
6.
Zurück zum Zitat Leibovich BC et al (2003) Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. Cancer 97(7):1663–1671CrossRefPubMed Leibovich BC et al (2003) Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. Cancer 97(7):1663–1671CrossRefPubMed
7.
Zurück zum Zitat Ljungberg B et al (2010) EAU guidelines on renal cell carcinoma: the 2010 update. Eur Urol 58(3):398–406CrossRefPubMed Ljungberg B et al (2010) EAU guidelines on renal cell carcinoma: the 2010 update. Eur Urol 58(3):398–406CrossRefPubMed
8.
Zurück zum Zitat Donat SM et al (2013) Follow-up for clinically localized renal neoplasms: AUA guideline. J Urol 190(2):407–416CrossRefPubMed Donat SM et al (2013) Follow-up for clinically localized renal neoplasms: AUA guideline. J Urol 190(2):407–416CrossRefPubMed
9.
Zurück zum Zitat Escudier B et al (2012) Renal cell carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 23(Suppl 7):vii65–vii71CrossRefPubMed Escudier B et al (2012) Renal cell carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 23(Suppl 7):vii65–vii71CrossRefPubMed
10.
Zurück zum Zitat Bruno JJ et al (2006) Renal cell carcinoma local recurrences: impact of surgical treatment and concomitant metastasis on survival. BJU Int 97(5):933–938CrossRefPubMed Bruno JJ et al (2006) Renal cell carcinoma local recurrences: impact of surgical treatment and concomitant metastasis on survival. BJU Int 97(5):933–938CrossRefPubMed
11.
Zurück zum Zitat Margulis V et al (2009) Predictors of oncological outcome after resection of locally recurrent renal cell carcinoma. J Urol 181(5):2044–2051CrossRefPubMed Margulis V et al (2009) Predictors of oncological outcome after resection of locally recurrent renal cell carcinoma. J Urol 181(5):2044–2051CrossRefPubMed
12.
Zurück zum Zitat Kavolius JP et al (1998) Resection of metastatic renal cell carcinoma. J Clin Oncol 16(6):2261–2266PubMed Kavolius JP et al (1998) Resection of metastatic renal cell carcinoma. J Clin Oncol 16(6):2261–2266PubMed
13.
Zurück zum Zitat Eggener SE et al (2008) Risk score and metastasectomy independently impact prognosis of patients with recurrent renal cell carcinoma. J Urol 180(3):873–878 discussion 878CrossRefPubMedCentralPubMed Eggener SE et al (2008) Risk score and metastasectomy independently impact prognosis of patients with recurrent renal cell carcinoma. J Urol 180(3):873–878 discussion 878CrossRefPubMedCentralPubMed
14.
Zurück zum Zitat Kwak C et al (2007) Metastasectomy without systemic therapy in metastatic renal cell carcinoma: comparison with conservative treatment. Urol Int 79(2):145–151CrossRefPubMed Kwak C et al (2007) Metastasectomy without systemic therapy in metastatic renal cell carcinoma: comparison with conservative treatment. Urol Int 79(2):145–151CrossRefPubMed
15.
Zurück zum Zitat Alt AL et al (2011) Survival after complete surgical resection of multiple metastases from renal cell carcinoma. Cancer 117(13):2873–2882CrossRefPubMed Alt AL et al (2011) Survival after complete surgical resection of multiple metastases from renal cell carcinoma. Cancer 117(13):2873–2882CrossRefPubMed
16.
Zurück zum Zitat Zerbi A et al (2008) Pancreatic metastasis from renal cell carcinoma: which patients benefit from surgical resection? Ann Surg Oncol 15(4):1161–1168CrossRefPubMed Zerbi A et al (2008) Pancreatic metastasis from renal cell carcinoma: which patients benefit from surgical resection? Ann Surg Oncol 15(4):1161–1168CrossRefPubMed
17.
Zurück zum Zitat Staehler MD et al (2010) Liver resection for metastatic disease prolongs survival in renal cell carcinoma: 12-year results from a retrospective comparative analysis. World J Urol 28(4):543–547CrossRefPubMed Staehler MD et al (2010) Liver resection for metastatic disease prolongs survival in renal cell carcinoma: 12-year results from a retrospective comparative analysis. World J Urol 28(4):543–547CrossRefPubMed
18.
Zurück zum Zitat Piltz S et al (2002) Long-term results after pulmonary resection of renal cell carcinoma metastases. Ann Thorac Surg 73(4):1082–1087CrossRefPubMed Piltz S et al (2002) Long-term results after pulmonary resection of renal cell carcinoma metastases. Ann Thorac Surg 73(4):1082–1087CrossRefPubMed
19.
Zurück zum Zitat Hofmann HS et al (2005) Prognostic factors and survival after pulmonary resection of metastatic renal cell carcinoma. Eur Urol 48(1):77–82CrossRefPubMed Hofmann HS et al (2005) Prognostic factors and survival after pulmonary resection of metastatic renal cell carcinoma. Eur Urol 48(1):77–82CrossRefPubMed
20.
Zurück zum Zitat Murthy SC et al (2005) Can we predict long-term survival after pulmonary metastasectomy for renal cell carcinoma? Ann Thorac Surg 79(3):996–1003CrossRefPubMed Murthy SC et al (2005) Can we predict long-term survival after pulmonary metastasectomy for renal cell carcinoma? Ann Thorac Surg 79(3):996–1003CrossRefPubMed
21.
Zurück zum Zitat Ljungberg B et al (1999) Follow-up guidelines for nonmetastatic renal cell carcinoma based on the occurrence of metastases after radical nephrectomy. BJU Int 84(4):405–411CrossRefPubMed Ljungberg B et al (1999) Follow-up guidelines for nonmetastatic renal cell carcinoma based on the occurrence of metastases after radical nephrectomy. BJU Int 84(4):405–411CrossRefPubMed
22.
Zurück zum Zitat Sandock DS, Seftel AD, Resnick MI (1995) A new protocol for the followup of renal cell carcinoma based on pathological stage. J Urol 154(1):28–31CrossRefPubMed Sandock DS, Seftel AD, Resnick MI (1995) A new protocol for the followup of renal cell carcinoma based on pathological stage. J Urol 154(1):28–31CrossRefPubMed
23.
Zurück zum Zitat Stephenson AJ et al (2004) Guidelines for the surveillance of localized renal cell carcinoma based on the patterns of relapse after nephrectomy. J Urol 172(1):58–62CrossRefPubMed Stephenson AJ et al (2004) Guidelines for the surveillance of localized renal cell carcinoma based on the patterns of relapse after nephrectomy. J Urol 172(1):58–62CrossRefPubMed
24.
Zurück zum Zitat Levy DA et al (1998) Stage specific guidelines for surveillance after radical nephrectomy for local renal cell carcinoma. J Urol 159(4):1163–1167CrossRefPubMed Levy DA et al (1998) Stage specific guidelines for surveillance after radical nephrectomy for local renal cell carcinoma. J Urol 159(4):1163–1167CrossRefPubMed
25.
Zurück zum Zitat Kim SP et al (2011) Outcomes and clinicopathologic variables associated with late recurrence after nephrectomy for localized renal cell carcinoma. Urology 78(5):1101–1106CrossRefPubMed Kim SP et al (2011) Outcomes and clinicopathologic variables associated with late recurrence after nephrectomy for localized renal cell carcinoma. Urology 78(5):1101–1106CrossRefPubMed
26.
Zurück zum Zitat Adamy A et al (2011) Clinical characteristics and outcomes of patients with recurrence 5 years after nephrectomy for localized renal cell carcinoma. J Urol 185(2):433–438CrossRefPubMed Adamy A et al (2011) Clinical characteristics and outcomes of patients with recurrence 5 years after nephrectomy for localized renal cell carcinoma. J Urol 185(2):433–438CrossRefPubMed
27.
Zurück zum Zitat Kroeger N et al (2014) Survival outcome and treatment response of patients with late relapse from renal cell carcinoma in the era of targeted therapy. Eur Urol 65(6):1086–1092CrossRefPubMed Kroeger N et al (2014) Survival outcome and treatment response of patients with late relapse from renal cell carcinoma in the era of targeted therapy. Eur Urol 65(6):1086–1092CrossRefPubMed
Metadaten
Titel
The blind spots in follow-up after nephrectomy or nephron-sparing surgery for localized renal cell carcinoma
verfasst von
Tim J. van Oostenbrugge
Stephanie G. C. Kroeze
J. L. H. Ruud Bosch
Harm H. E. van Melick
Publikationsdatum
01.06.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 6/2015
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-014-1390-6

Weitere Artikel der Ausgabe 6/2015

World Journal of Urology 6/2015 Zur Ausgabe

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.